Login / Signup

Type III interferon is a critical regulator of innate antifungal immunity.

Vanessa EspinosaOrchi DuttaConstance McElrathPeicheng DuYun-Juan ChangBryan CicciarelliAmy PitlerIan WhiteheadJoshua J ObarJoan E DurbinSergei V KotenkoAmariliz Rivera
Published in: Science immunology (2018)
Type III interferons (IFN-λs) are the most recently found members of the IFN cytokine family and engage IFNLR1 and IL10R2 receptor subunits to activate innate responses against viruses. We have identified IFN-λs as critical instructors of antifungal neutrophil responses. Using Aspergillus fumigatus (Af) as a model to study antifungal immune responses, we found that depletion of CCR2+ monocytes compromised the ability of neutrophils to control invasive fungal growth. Using an unbiased approach, we identified type I and III IFNs as critical regulators of the interplay between monocytes and neutrophils responding to Af We found that CCR2+ monocytes are an important early source of type I IFNs that prime optimal expression of IFN-λ. Type III IFNs act directly on neutrophils to activate their antifungal response, and mice with neutrophil-specific deletion of IFNLR1 succumb to invasive aspergillosis. Dysfunctional neutrophil responses in CCR2-depleted mice were rescued by adoptive transfer of pulmonary CCR2+ monocytes or by exogenous administration of IFN-α and IFN-λ. Thus, CCR2+ monocytes promote optimal activation of antifungal neutrophils by initiating a coordinated IFN response. We have identified type III IFNs as critical regulators of neutrophil activation and type I IFNs as early stimulators of IFN-λ expression.
Keyphrases
  • dendritic cells
  • type iii
  • immune response
  • regulatory t cells
  • candida albicans
  • poor prognosis
  • transcription factor
  • stem cells
  • inflammatory response
  • cell therapy
  • metabolic syndrome
  • adipose tissue
  • long non coding rna